Search Results - James F. Trotter
- Showing 1 - 20 results of 38
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal by Jeffrey Campsen, Michael A. Zimmerman, James F. Trotter, Michael Wachs, Thomas H. Bak, Tracy Steinberg, Maria Kaplan, Franklin L. Wright, Igal Kam
Published 2008Artigo -
12
Outcomes of living donor liver transplantation for acute liver failure: The adult-to-adult living donor liver transplantation cohort study by Jeffrey Campsen, Andrés T. Blei, Jean C. Emond, James E. Everhart, Chris E. Freise, Anna S. Lok, Sammy Saab, Karen Wisniewski, James F. Trotter
Published 2008Artigo -
13
Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation by Marcelo Kugelmas, Purnima Spiegelman, Michael J. Osgood, David A. Young, James F. Trotter, Tracy Steinberg, Michael Wachs, Thomas H. Bak, Igal Kam, Gregory T. Everson
Published 2003Artigo -
14
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: A multicenter cohort study by Jennifer C. Lai, Jacqueline G. O’Leary, James F. Trotter, Elizabeth C. Verna, Robert S. Brown, R. Todd Stravitz, Jeffrey D. Duman, Lisa Forman, Norah A. Terrault
Published 2012Artigo -
15
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma by Christian Toso, James F. Trotter, Alice C. Wei, David L. Bigam, Shimul A. Shah, Joshua Lancaster, David Grant, Paul D. Greig, A. M. James Shapiro, Norman M. Kneteman
Published 2008Artigo -
16
Impact of Hepatopulmonary Syndrome on Quality of Life and Survival in Liver Transplant Candidates by Michael B. Fallon, Michael J. Krowka, Robert S. Brown, James F. Trotter, Steven Zacks, Kari E. Roberts, Vijay H. Shah, Neil Kaplowitz, Lisa Forman, Keith Wille, Steven M. Kawut
Published 2008Artigo -
17
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy by James R. Burton, Jacqueline G. O’Leary, Elizabeth C. Verna, Varun Saxena, Jennifer L. Dodge, Richard T. Stravitz, Joshua Levitsky, James F. Trotter, Gregory T. Everson, Robert S. Brown, Norah A. Terrault
Published 2014Artigo -
18
Hepatitis C virus–infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men by Jennifer C. Lai, Elizabeth C. Verna, Robert S. Brown, Jacqueline G. O’Leary, James F. Trotter, Lisa Forman, Jeffrey D. Duman, Richard G. Foster, Todd R. Stravitz, Norah A. Terrault
Published 2011Artigo -
19
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis by Mary E. Rinella, James F. Trotter, Manal F. Abdelmalek, Angelo H. Paredes, Margery A. Connelly, Mark Jaros, Lei Ling, Stephen J. Rossi, Alex M. DePaoli, Stephen A. Harrison
Published 2018Artigo -
20
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation by James F. Trotter, Karen Wisniewski, Norah A. Terrault, James E. Everhart, Milan Kinkhabwala, Robert M. Weinrieb, Jeffrey H. Fair, Robert A. Fisher, Alan J. Koffron, Sammy Saab, Robert M. Merion
Published 2007Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Transplantation
Liver transplantation
Gastroenterology
Disease
Surgery
Liver disease
Cohort
Cirrhosis
Living donor liver transplantation
Pathology
Alternative medicine
Fatty liver
Intensive care medicine
Placebo
Fibrosis
Receptor
Steatohepatitis
Confidence interval
Donation
Immunosuppression
Physics
Primary sclerosing cholangitis
Tacrolimus
Agonist
Biology
Chronic liver disease
Clinical endpoint
Economic growth